Related Experiment Video
Updated: May 22, 2026
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Recent gains in clinical multiple sclerosis research.
T F Runia1, E D van Pelt-Gravesteijn, R Q Hintzen
1Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
CNS & Neurological Disorders Drug Targets
|May 16, 2012
Summary
Multiple sclerosis (MS), a central nervous system disorder affecting millions, involves genetic and environmental factors like Epstein-Barr virus and low vitamin D. Recent research highlights diagnostic criteria and disease progression, including childhood onset and neuromyelitis optica.
Area of Science:
- Neurology
- Immunology
- Epidemiology
Background:
- Multiple sclerosis (MS) is a prevalent neurological disorder impacting the central nervous system (CNS), primarily affecting young individuals globally.
- The etiology of MS is multifactorial, involving a complex interplay between genetic predisposition and environmental triggers.
- Over 2.5 million people worldwide are affected by this chronic CNS condition.
Purpose of the Study:
- To summarize recent advancements in clinical multiple sclerosis research.
- To discuss the role of genetic and environmental factors in MS development.
- To provide insights into diagnostic criteria, disease progression, and related conditions like neuromyelitis optica (NMO).
Main Methods:
- Review of recent clinical MS research findings.
- Analysis of epidemiological data regarding MS prevalence and risk factors.
- Discussion of diagnostic criteria and clinical presentations of MS and NMO.
Main Results:
- Genetic susceptibility combined with Epstein-Barr virus infection appears crucial for MS development, with over 50 identified genetic loci.
- MS prevalence shows a latitudinal gradient, suggesting a link between sunlight exposure, vitamin D levels, and reduced MS risk.
- Revised McDonald Diagnostic Criteria may allow earlier MS diagnosis; disease courses include relapsing-remitting, secondary progressive, and primary progressive forms, with childhood-onset MS presenting unique challenges.
Conclusions:
- Recent clinical research has significantly advanced the understanding of MS etiology, diagnosis, and progression.
- Environmental factors, particularly vitamin D, and genetic predispositions are key contributors to MS risk.
- Distinguishing MS from other CNS demyelinating diseases like NMO is critical for accurate diagnosis and management.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...